Biofeedback Wearable Devices

𝗗𝗼 𝘆𝗼𝘂 𝗳𝗲𝗲𝗹 𝗪𝗲𝗮𝗿𝗮𝗯𝗹𝗲𝘀 𝗮𝗿𝗲 𝗹𝗶𝘃𝗶𝗻𝗴 𝘂𝗽 𝘁𝗼 𝘁𝗵𝗲𝗶𝗿 𝗲𝘅𝗽𝗲𝗰𝘁𝗮𝘁𝗶𝗼𝗻𝘀? Because this breakthrough just raised the bar significantly. Researchers have developed a wearable device that monitors glucose levels through sweat – and it doesn't stop there. This disposable patch integrates real-time glucose monitoring with automated transdermal drug delivery for diabetes management. 𝗛𝗲𝗿𝗲'𝘀 𝘄𝗵𝘆 𝘁𝗵𝗶𝘀 𝗺𝗮𝘁𝘁𝗲𝗿𝘀: ✅ 𝗡𝗼𝗻-𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 – No more painful finger pricks ✅ 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀 𝘁𝗿𝗮𝗰𝗸𝗶𝗻𝗴 – Real-time glucose data from sweat analysis ✅ 𝗦𝗺𝗮𝗿𝘁 𝗱𝗿𝘂𝗴 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 – Automated treatment response when glucose levels spike ✅ 𝗪𝗲𝗮𝗿𝗮𝗯𝗹𝗲 & 𝗱𝗶𝘀𝗽𝗼𝘀𝗮𝗯𝗹𝗲 – Practical for everyday use This isn't science fiction. It's soft bioelectronics on human skin, creating a closed-loop system that monitors AND treats diabetes simultaneously. 𝗧𝗵𝗲 𝗯𝗶𝗴𝗴𝗲𝗿 𝗽𝗶𝗰𝘁𝘂𝗿𝗲? This technology represents the convergence of AI, wearables, and connected care – three pillars transforming healthcare delivery. We're moving from reactive treatment to proactive, personalized health management. For healthcare organizations exploring digital transformation, innovations like this answer the question: wearables aren't just living up to expectations – they're exceeding them by becoming active treatment devices, not just passive monitors. 𝗧𝗵𝗲 𝗿𝗲𝗮𝗹 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻: 𝗛𝗼𝘄 𝗾𝘂𝗶𝗰𝗸𝗹𝘆 𝗰𝗮𝗻 𝘄𝗲 𝘀𝗰𝗮𝗹𝗲 𝘁𝗵𝗶𝘀 𝗳𝗿𝗼𝗺 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘁𝗼 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗰𝗮𝗿𝗲? What's your take? Are non-invasive biosensors the next frontier in chronic disease management? 📖 Research: Science Advances (DOI: 10.1126/sciadv.1601314) For more Wearables News and Expertise follow João Bocas #DigitalHealth #AIinHealthcare #Wearables #DiabetesCare #HealthTech #ConnectedCare #Innovation #HealthcareTransformation

An important new study published in the peer-reviewed journal, Gastroenterology, has revealed the potential of wearable devices to predict flares of inflammatory bowel disease (IBD) up to seven weeks in advance. Researchers at Mount Sinai found that physiological data collected from devices like the Oura Ring, Fitbit, and Apple Watch can identify subtle changes in heart rate variability, heart rate, oxygenation, and activity patterns that precede flare-ups. Notably, Oura Ring proved particularly valuable in capturing these physiological changes. The ring's ability to continuously monitor heart rate variability, a key indicator of autonomic nervous system activity, allowed researchers to detect subtle shifts that often precede inflammation. This breakthrough could transform how IBD is managed. By providing early warning signs, wearable devices can empower patients and doctors to proactively adjust treatment plans, potentially reducing the severity and duration of flares. This non-invasive, continuous monitoring offers a significant advantage over traditional methods like blood tests and colonoscopies, which can be inconvenient and only provide a snapshot of disease activity at a given moment in time. Beyond IBD, the study's findings pave the way for personalized management of other chronic conditions, where wearable data is integrated with artificial intelligence algorithms to predict flares and manage disease on an individual basis. This could revolutionize the lives of the hundreds of millions of people living with chronic diseases in the US alone, offering a new level of control and improved quality of life. Oura’s capabilities as a powerful public research tool are no secret to those of us who have spent time with the product, and I’m thrilled to see others harnessing the power of Oura Ring to improve patient outcomes. #WithOura https://lnkd.in/ghUJ7zwV

Do you ever wonder why PPG (Photoplethysmography) is such a critical component of wearable devices? PPG technology, which uses light to measure blood volume changes in tissues, has become a cornerstone for monitoring vital signs like heart rate, oxygen saturation, and even stress levels. But what makes it truly transformative is its versatility across various health applications. 💡 How PPG Works: PPG sensors emit light into the skin and measure changes in light absorption caused by blood flow. This simple, non-invasive technology is packed with potential for real-time health monitoring. 💊 Disease Areas Leveraging PPG: Cardiology: Detecting arrhythmias, monitoring heart rate variability, and even aiding in early detection of atrial fibrillation. Pulmonology: Measuring blood oxygen levels to monitor conditions like COPD and sleep apnea. Endocrinology: Helping manage diabetes by providing data on circulation and stress levels. Neurology: Monitoring stress and relaxation patterns to support conditions like anxiety and depression. 🩺 In Clinical Trials: PPG-enabled wearables provide continuous, real-world data, offering insights that static, clinic-based tests often miss. They empower researchers to: * Monitor disease progression more effectively. * Identify early responses to treatments. Enhance patient engagement by involving them in their own care journey. Within clinical trials, PPG becomes the silent observer, gathering truths in real time. At Delve Health, we embrace this gentle watcher, integrating PPG-enabled wearables to uncover the narratives woven beneath our skin. #DigitalHealth #Wearables #PPG #ClinicalTrials #HealthTech

The 2025 CPT code update introduced new codes for Digital Mental Health Treatment Device (G0552, G0553, G0554). As of the time of posting, there is only one cleared treatment to use with this code: Prism for PTSD. This ‘self-neuromodulation’ device facilitates a biofeedback-based intervention for PTSD: ↳ Patients wear an EEG cap and watch a computer simulation of a chaotic hospital waiting room with agitated people and crying babies. ↳ Software generates a personalized "brain fingerprint" (based on EEG data) that patients learn to modify through practice of mental strategies. ↳ When patients successfully achieve a calm “fingerprint”, the virtual scene becomes peaceful. ↳ Patients complete 15 sessions over 8 weeks, with each session lasting about 30 minutes. With continued practice, PTSD symptoms decrease in the real world. What’s going on here? ↳ The “brain fingerprint” reflects amygdala activity, which is consistently elevated in PTSD. ↳ The intervention indirectly trains patients to calm their amygdala. ↳ Reduction in amygdala hyperactivity is correlated with symptomatic improvement. Key research - in a study of 79 patients with chronic PTSD: ↳ 67% achieved clinically significant symptom improvement after 8 weeks ↳ Benefits lasted at least 3 months after treatment ended ↳ Average symptom reduction was double what's considered meaningful improvement ↳ Side effects were mild and temporary (headaches, fatigue) ↳ 90% of patients completed the full treatment Research limitations: ↳ Trial was open-label without a control group. ↳ We do not have data comparing Prism to established standards like TF-CBT. Theoretical advantages of Prism: ↳ does not require patients to re-live trauma ↳ can be used independently of medications, or as augmentation ↳ learned skills translate to daily life Key Takeaways: ↳ Prism for PTSD is the first FDA-cleared DMHT device, offering a novel approach to PTSD treatment based in biofeedback. ↳ It's designed as an add-on to standard care, not a replacement. ↳ While more research is needed, initial results suggest it could be a valuable addition to PTSD care, especially for patients who haven't responded well to traditional treatments or prefer non-medication approaches. ↳ The technology represents an important step toward precision psychiatry, using brain biomarkers measured in real-time to guide treatment. --------------------- ⁉️ Would you prescribe Prism for your patients? 🔄 Share this post to help clinicians expand their knowledge of digital therapeutics. ✅ Follow me for more on psychiatry, translational neuroscience, and medical informatics.

Smart Pelvic Devices: Precision Tools for Recovery, Strength, and Confidence View My Portfolio. Pelvic health sits at the intersection of mobility, continence, intimacy, and overall quality of life—yet it’s historically underserved. Smart pelvic devices are changing that with sensors, guided training, and coach-like feedback that make progress measurable and personalized. What “smart” looks like Biofeedback sensors (pressure/EMG) visualize contractions and relaxation in real time. Adaptive training plans adjust reps, hold times, and rest based on performance trends. Clinician-mode & home-mode support both supervised therapy and privacy-first self-care. Progress dashboards track adherence, strength, endurance, and coordination over weeks. Where they help Postpartum recovery: rebuilding coordination and confidence after birth. Perimenopause/menopause: addressing tissue changes and comfort. Pelvic floor dysfunction: support for urgency, mild stress leaks, and muscle tension patterns. Pre/post-surgical rehab: structured protocols with objective metrics. Outcomes that matter Greater muscle awareness and technique (not just “squeeze harder”). Improvements in strength and endurance with consistent 8–12 week programs. Better mind–body control, which can translate to comfort and confidence in daily life. Safety, privacy, and design Medical-grade, body-safe materials with clear cleaning guidance. Data minimization: on-device analytics where possible; opt-in sharing only. Human-centered ergonomics: quiet operation, gentle start routines, and adjustable goals. Accessibility: inclusive sizing, visual and audio cues, and multilingual coaching. The opportunity for builders & clinicians Protocol libraries co-created with pelvic PTs and urology/OBGYN partners. Integrations with sleep, stress, and posture apps to see whole-person trends. Outcomes research that focuses on adherence and comfort—not just peak strength. At V For Vibes, we see smart pelvic devices as part of a broader wellness toolkit—bridging clinical best practices with approachable, at-home routines that respect privacy, dignity, and pace. #VForVibes #PelvicHealth #DigitalTherapeutics #Biofeedback #WomenInHealthTech #HumanCenteredDesign #RehabTech #MenopauseCare #PostpartumCare #SexTech